Evaluating long-term survival and cardiac efficacy of a gene therapy for Duchenne muscular dystrophy
A recent study published in the journal Human Gene Therapy evaluated the long-term survival and cardiac efficacy of the gene therapy delandistrogene moxeparvovec in a rat model of Duchenne muscular dystrophy (DMD).
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2024-12-05 12:02:242024-12-05 12:02:24Evaluating long-term survival and cardiac efficacy of a gene therapy for Duchenne muscular dystrophy
